Publications by authors named "Peter Pisters"

Claim this Profile
I
Impact of Cancer Care Regionalization on Patient Volume.
Kevin J Contrera, Samantha Tam, Kristen Pytynia, Eduardo M Diaz, Amy C Hessel, Peter W T Pisters

Ann Surg Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis.
David Hui, Nico Nortje, Marina George, Kaycee Wilson, Diana L Urbauer, Peter Pisters

J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A flexible-hazards cure model with application to patients with soft tissue sarcoma.
Can Xie, Xuelin Huang, Ruosha Li, Peter W T Pisters

Stat Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MD Anderson's 10-year experience with regional surgical oncology in the Houston area locations.
Richard A Ehlers, Peter P W Pisters, Nancy D Perrier

Surgery· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Goal Concordant Care Among 10 Leading Academic U.S. Cancer Hospitals: A Collaboration of the Alliance of Dedicated Cancer Centers.
Kristen K McNiff, Michael A Caligiuri, Nancy E Davidson, William Farrar, Richard I Fisher, Peter W T Pisters

Oncologist· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial.
Alice C Wei, Fang-Shu Ou, Qian Shi, Xiomara Carrero, Eileen M O'Reilly, Peter Pisters

Ann Surg Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance).
Waddah B Al-Refaie, Paul A Decker, Karla V Ballman, Peter W T Pisters, Mitchell C Posner

Ann Surg Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial.
James Fleshman, Megan E Branda, Daniel J Sargent, Anne Marie Boller, Virgilio V George, Peter W T Pisters

Ann Surg· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regionalization Does Not Equal Integration.
Adalsteinn D Brown, Peter W T Pisters, C David Naylor

Healthc Pap· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supporting hospital renewal through strategic environmental sustainability programs.
Peter Pisters, Belinda Bien, Stewart Dankner, Ed Rubinstein, Fatima Sheriff

Healthc Manage Forum· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.
Jordan M Cloyd, Matthew H G Katz, Laura Prakash, Gauri R Varadhachary, Robert A Wolff, Peter W T Pisters

J Gastrointest Surg· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bayesian multivariate joint frailty model for disease recurrences and survival.
Sijin Wen, Xuelin Huang, Ralph F Frankowski, Janice N Cormier, Peter Pisters

Stat Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma.
William W Tseng, Shouhao Zhou, Christina A To, Peter F Thall, Alexander J Lazar, Peter W T Pisters

Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
Li Liu, Matthew H Katz, Sun M Lee, Laurice K Fischer, Laura Prakash, Peter W Pisters

Am J Surg Pathol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial.
James Fleshman, Megan Branda, Daniel J Sargent, Anne Marie Boller, Virgilio George, Peter W T Pisters

JAMA· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicystic dedifferentiated retroperitoneal liposarcoma: tumour cyst fluid analysis and implications for management.
Mitri Khoury, Geok Choo Sim, Michiko Harao, Laszlo Radvanyi, Behrang Amini, Peter W T Pisters

BMJ Case Rep· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer.
Christina L Roland, Anthony D Yang, Matthew H G Katz, Deyali Chatterjee, Huamin Wang, Peter W Pisters

Ann Surg Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors.
Brian K Bednarski, Dejka M Araujo, Min Yi, Keila E Torres, Alexander Lazar, Peter W T Pisters

Ann Surg Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection?
William W Tseng, John E Madewell, Wei Wei, Neeta Somaiah, Alexander J Lazar, Peter W T Pisters

Ann Surg Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer.
Ching-Wei D Tzeng, Aparna Balachandran, Mediha Ahmad, Jeffrey E Lee, Sunil Krishnan, Peter W T Pisters

HPB (Oxford)· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
Christopher L Corless, Karla V Ballman, Cristina R Antonescu, Violetta Kolesnikova, Robert G Maki, Peter W T Pisters

J Clin Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.
Hop S Tran Cao, Alpana Balachandran, Huamin Wang, Graciela M Nogueras-González, Christina E Bailey, Peter W T Pisters

J Gastrointest Surg· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification.
Ching-Wei D Tzeng, Matthew H G Katz, Jason B Fleming, Jeffrey E Lee, Peter W T Pisters

J Gastrointest Surg· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival.
Ching-Wei D Tzeng, Hop S Tran Cao, Jeffrey E Lee, Peter W T Pisters, Gauri R Varadhachary

J Gastrointest Surg· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma.
Deyali Chatterjee, Matthew H Katz, Asif Rashid, Jeannelyn S Estrella, Hua Wang, Peter W Pisters

Histopathology· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis